For example, pathogenic mutations for TP53 have been reported in oral rinses from both cancer patients and non-cancer controls [50], thereby challenging the significance of ctDNA in surveillance tests for HNSCC. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.